Asklepios BioPharmaceutical, Inc. (AskBio) 在哪里?
Asklepios BioPharmaceutical, Inc. (AskBio) 的总部位于 20 T.W. Alexander Drive, Durham, North Carolina, USA, 27709
Asklepios BioPharmaceutical, Inc. (AskBio) 的电话号码是多少?
Asklepios BioPharmaceutical, Inc. (AskBio) 的电话号码是 +1 919-561-6210
Asklepios BioPharmaceutical, Inc. (AskBio) 的官方网站是什么?
Asklepios BioPharmaceutical, Inc. (AskBio) 的公司官方网站是 http://www.askbio.com
Asklepios BioPharmaceutical, Inc. (AskBio) 是做什么的?
AskBio is a leading, clinical-stage gene therapy company dedicated to developing AAV gene therapies for genetic and complex disorders. Learn more about our gene therapy technology and current clinical trials.
Asklepios BioPharmaceutical, Inc. (AskBio) 的业务有哪些?
aav,adenoassociated virus,gene therapy,rare disease,aav manufacturing
Asklepios BioPharmaceutical, Inc. (AskBio) 的年收入是多少?
Asklepios BioPharmaceutical, Inc. (AskBio) 的收入是 9000000美元
Asklepios BioPharmaceutical, Inc. (AskBio) 有多少员工?
Asklepios BioPharmaceutical, Inc. (AskBio) 有 410 名员工
Asklepios BioPharmaceutical, Inc. (AskBio) 属于哪个行业?
Asklepios BioPharmaceutical, Inc. (AskBio) 从事以下行业: research
Asklepios BioPharmaceutical, Inc. (AskBio) 使用什么技术?
Asklepios BioPharmaceutical, Inc. (AskBio) 使用的一些流行技术包括: Amazon AWS,GoDaddy Hosting,Google Tag Manager,Mobile Friendly,Nginx,Outlook,Ubuntu,Varnish,Wix,WordPress.org,Workday Recruit
如何联系 Asklepios BioPharmaceutical, Inc. (AskBio)?
Asklepios BioPharmaceutical, Inc. (AskBio) 联系信息:
电话号码:+1 919-561-6210,
网站:http://www.askbio.com,
邮箱:ala***@***.com
Asklepios BioPharmaceutical, Inc. (AskBio) 的社交媒体链接是什么?
Asklepios BioPharmaceutical, Inc. (AskBio) 领英:http://www.linkedin.com/company/askbio,fackbook:https://www.facebook.com/askbio/,twitte:https://twitter.com/ask_bio
Asklepios BioPharmaceutical, Inc. (AskBio) 是一家上市公司吗?
不是
Asklepios BioPharmaceutical, Inc. (AskBio) 的最后一轮融资是什么时候?
Asklepios BioPharmaceutical, Inc. (AskBio)在2020-10-26T00:00:00.000+00:00结束了最后一轮融资,金额达2.0M£。
谁投资 Asklepios BioPharmaceutical, Inc. (AskBio)?
Asklepios BioPharmaceutical, Inc. (AskBio) 有 7 家投资者,包括 Scottish Enterprise、TPG Capital, Vida Ventures、Scottish Enterprise、Calculus Capital、、Calculus Capital、Muscular Dystrophy Association。